John B Henneman Iii Anika Therapeutics, Inc. (ANIK) insider trading activity

John B Henneman Iii is Director of Anika Therapeutics, Inc.. Currently has a direct ownership of 49,871 shares of ANIK, which is worth approximately $548,581. The most recent transaction as insider was on Jun 20, 2025, when has been sold 14,164 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.9K

39.67% 3M change

39.67% 12M change

Total Value Held $548,581

JOHN B HENNEMAN III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	BUY Grant, award, or other acquisition	-	14,164 Added 22.12%	49,871 Common Stock
Jul 09 2024	BUY Grant, award, or other acquisition	-	5,771 Added 13.91%	35,707 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	6,500 Added 17.84%	29,936 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	7,954 Added 25.34%	23,436 Common Stock
Jun 16 2021	BUY Grant, award, or other acquisition	-	4,172 Added 21.23%	15,482 Common Stock
May 18 2021	BUY Open market or private purchase	$85,720 $42.86 p/Share	2,000 Added 15.03%	11,310 Common Stock

Also insider at

SPNE

SeaSpine Holdings Corp Healthcare

Director

APRE

Aprea Therapeutics, Inc. Healthcare

Director

RCM

R1 RCM Inc. Healthcare

OFIX

Orthofix Medical Inc. Healthcare

JBH